Updates

CONTACT US

July 23, 2024

Glenmark Drug Recall: Potassium Chloride Extended Release Capsules

On June 24, 2024, the FDA published a recall of certain batches of Glenmark Pharmaceuticals’ Potassium Chloride Extended Release Capsules because they failed to meet the…

View Details

July 1, 2024

Breckenridge Duloxetine Recall Expands—Now Approximately 70 Million Pills

As The Block Firm previously revealed, Breckenridge Pharmaceutical, Inc. has recalled at least 50 million tablets of Duloxetine due to the presence of nitrosamines, potent…

View Details

June 4, 2024

Court Grants Final Approval to $46.5 Million Class Action Settlement

This month The Block Firm obtained final approval of a $46.5 million class action settlement, which will benefit over a million class members nationwide. The…

View Details

May 30, 2024

The Block Firm Files Class Action About Contaminated Drugs

This week The Block Firm, partnering with our good friends at Anderson & Shah, filed a class action (read complaint here) against the manufacturer of…

View Details

May 17, 2024

FDA Recalls Duloxetine: The Block Firm continues to investigate

The U.S. Food and Drug Administration (FDA) has recently issued a recall for duloxetine, a medication commonly prescribed for depression and anxiety. If you or…

View Details

May 8, 2024

The Block Firm Investigates the Presence of Carcinogens in Duloxetine (Generic Cymbalta)

Millions of Americans take the drug duloxetine—a generic form of Cymbalta—for depression, pain, and anxiety. According to a recent FDA announcement, tens of millions of…

View Details

March 20, 2024

The Block Firm Investigates Unapproved Thyroid Drug, Adthyza

The Block Firm is investigating a new potential case regarding Adthyza, an unapproved thyroid drug manufactured by Azurity. At The Block Firm, we believe that…

View Details

March 15, 2024

Unapproved Prescription Drugs Are Rampant—and Can Harm Your Health.

Many Americans trust that prescription drugs have been approved by the Food & Drug Administration and are safe and effective for patients to take. After…

View Details

February 20, 2024

Neptune’s Fix Elixir Recalled by the FDA Due to Potentially Harmful Ingredient, Tianeptine

The Block Firm is investigating a potential class action lawsuit against Neptune’s Resources, LLC, the manufacturer of Neptune’s Fix Elixir, Neptune’s Fix Extra Strength Elixir,…

View Details

February 16, 2024

The Block Firm Receives Preliminary Approval of $46.5 Million Class Action Settlement

Since 2022, The Block Firm has been pursuing a class action against Acella Pharmaceuticals, the manufacturer of NP Thyroid. The class action alleges that Acella…

View Details

OUR PEOPLE

We’re here when you need us.

Group 170